MANNATECH INC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
MANNATECH INC (MTEX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum of 3.90% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum · last filed 2026-04-15
- MANNATECH INC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2025 was 3.90%, a 9.30% decline from fiscal 2024.
- MANNATECH INC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2024 was 4.30%, a 7.50% increase from fiscal 2023.
- MANNATECH INC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2023 was 4.00%, a 37.93% increase from fiscal 2022.
- MANNATECH INC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2022 was 2.90%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | 3.90% 10-K · filed 2026-04-15 | ||
| 2025-09-30 | 3.90% 10-Q · filed 2025-11-12 | ||
| 2024-12-31 | 4.30% 10-K · filed 2026-04-15 | ||
| 2023-12-31 | 4.00% 10-K · filed 2025-03-26 | ||
| 2022-12-31 | 2.90% 10-K · filed 2024-03-28 | ||
| 2018-12-31 | 2.50% 10-K · filed 2020-03-26 | ||
| 2016-12-31 | 1.10% 10-K · filed 2018-03-26 | ||
| 2015-12-31 | 1.20% 10-K · filed 2017-03-14 | ||
| 2014-12-31 | 1.30% 10-K · filed 2016-03-15 | ||
| 2013-12-31 | 0.70% 10-K · filed 2015-03-10 | 0.66% 10-K · filed 2014-03-18 | |
| 2012-12-31 | 0.62% 10-K · filed 2014-03-18 | ||
| 2011-12-31 | 0.78% 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |